SCHEMBL7787086

SCHEMBL7787086

CON(c1ccccc1)C(C)(C)C(=O)OP(=O)(O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
NPSR1 Q6W5P4 3/20 0.35
RAB9A P51151 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTT P42858 1/20 0.34
KCNN4 O15554 1/20 0.34
SRC P12931 2/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
LAP3 P28838 1/20 0.32
ALDH1A1 P00352 3/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7113639 0.88 KMT2A (0.34) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL7212918 0.72 ALDH1A1 (0.35) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL1114389 0.69 KMT2A (0.40) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL1297782 0.69 MEN1 (0.44) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL9508170 0.69 KCNN4 (0.43) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL12562393 0.68 KCNN4 (0.36) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL4894696 0.68 KCNN4 (0.42) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL9507537 0.68 MEN1 (0.39) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL4893317 0.68 KCNN4 (0.42) KMT2AMEN1NPSR1RAB9ACYP3A4
SCHEMBL28567703 0.67 FDPS (0.47) CYP3A4CYP2C9CYP2C19SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031745-A1 Antiviral purine derivatives UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031745-A1 Antiviral purine derivatives PNP, TYMP, MTAP KMT2A 3808/4885MEN1 1563/4885NPSR1 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.